Novo Nordisk shares dive 9% after heart medicine fails trial

Shares of Novo Nordisk nosedived as much as 10% after the drugmaker said a late-stage heart drug trial failed to reduce major cardiovascular events compared to a placebo. While the experimental medicine, ziltivekimab, did show some biological effect, it didn’t translate into a statistically meaningful reduction in so-called MACE, defined as cardiovascular death, non-fatal heart attack…

Read More

SK Hynix, Samsung stocks: AI rally roars back

Omar Marques | Lightrocket | Getty Images South Korea’s chip heavyweights SK Hynix and Samsung Electronics skyrocketed in Seoul on Friday, tracking a sharp rally in U.S. technology stocks after blockbuster earnings from Amazon and Microsoft revived optimism around artificial intelligence spending. SK Hynix was last trading over 25% higher, putting it on course for…

Read More

Coinbase shares fall after crypto exchange posts disappointing second-quarter results

Jakub Porzycki | Nurphoto | Getty Images Coinbase shares dropped in extended trading on Thursday after the crypto platform posted a wider-than-expected loss for the second quarter, underscoring the continued troubles resulting from a deepening crypto winter despite its efforts to diversify revenue. Here’s how Coinbase performed in its quarter ended June 30, compared with what Wall…

Read More